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RNA binding proteinExcessive mitochondrial ﬁssion is associated with the pathogenesis of neurodegenerative diseases. Dynamin-
related protein 1 (Drp1) possesses speciﬁc ﬁssion activity in the mitochondria and peroxisomes. Various post-
translational modiﬁcations of Drp1 are known to modulate complex mitochondrial dynamics. However, the
post-transcriptional regulation of Drp1 remains poorly understood. Here, we show that the heterogeneous
nuclear ribonucleoprotein A1 (hnRNP A1) regulates Drp1 expression at the post-transcriptional level. hnRNP
A1 directly interacts with Drp1 mRNA at its 3′UTR region, and enhances translation potential without affecting
mRNA stability. Down-regulation of hnRNP A1 induces mitochondrial elongation by reducing Drp1 expression.
Moreover, depletion of hnRNP A1 suppresses 3-NP-mediated mitochondrial ﬁssion and dysfunction. In contrast,
over-expression of hnRNP A1 promotesmitochondrial fragmentation by increasing Drp1 expression. Additional-
ly, hnRNPA1 signiﬁcantly exacerbates 3-NP-inducedmitochondrial dysfunction and cell death in neuroblastoma
cells. Interestingly, treatment with 3-NP induces subcellular translocation of hnRNP A1 from the nucleus to the
cytoplasm, which accelerates the increase in Drp1 expression in hnRNP A1 over-expressing cells. Collectively,
our ﬁndings suggest that hnRNP A1 controls mitochondrial dynamics by post-transcriptional regulation of Drp1.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Mitochondria are important organelles involved in the production of
energy necessary for cell survival and homeostasis [1,2]. Mitochondrial
morphology depends on the balance between two opposing processes,
mitochondrial ﬁssion and fusion, collectively termed as mitochondrial
dynamics. The disruption of this balance results in mitochondrial
dysfunction and aberrations in physiological neuronal functions, such
as exon transport, synaptic transmission, calciumhomeostasis, and neu-
ronal development [3]. Neurons are especially susceptible to changes in
mitochondrial dynamics, such asmitochondrialmovement, distribution
and function, due to their high-energy demand [4,5]. Abnormalities in
mitochondrial dynamics are implicated in the early events of neurode-
generative diseases such as Huntington's disease (HD), Alzheimer'st-West Medical Science, Kyung
ngin-si, Gyeonggi-do 446-701,
o@khu.ac.kr (D.-H. Cho).
. This is an open access article underdisease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis
(ALS) and Charcot–Marie–Tooth neuropathy (CMT) [6,7]. HD is an auto-
somal dominant condition caused by abnormal expansions in a CAG re-
peat tract in the huntingtin gene (HTT), resulting in an abnormally long
poly-glutamine stretch in the protein which renders it aggregate-prone
[8]. The 3-nitropropionic acid (3-NP) toxin acts amitochondrial respira-
tory complex II inhibitor, which leads to anHD-like pattern of cell loss in
rodents [9]. Expression of mutant HTT and 3-NP treatment trigger both
mitochondrial ﬁssion and mitochondrial dysfunction, and eventually
induce neurotoxicity with disrupted axonal transport and synaptic
degeneration [10–15].
The mitochondrial ﬁssion and fusion machineries are continuously
controlled by several largeGTPase proteins.Mitochondrialﬁssion isme-
diated by dynamin-related protein 1 (Drp1), a dynamin GTPase protein
[16]. Drp1 primarily located in the cytosol is recruited to the mitochon-
dria and interacts with outer membrane anchoring proteins such as
Fis1, mitochondria ﬁssion factor, mitochondria dynamics protein 49
and 50 kDa [6,17,18]. At the constriction sites, Drp1 assembles ring-
like complex to promote mitochondrial fragmentation process using
GTPase hydrolysis [19]. On the other hand, the mitochondrial fusion is
controlled by other large GTPase proteins, mitofusin 1/2 (Mfn1/2) andthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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mitochondrial membranes (OMM) of adjacent mitochondria. And
inner mitochondrial membrane (IMM) fusion is regulated by OPA1
which plays role in maintaining mitochondrial DNA and controlling
cristae remodeling [21]. Previous studies have reported that Drp1
activity is regulated by several post-translational modiﬁcations, such
as phosphorylation, S-nitrosylation, SUMOylation, ubiquitination, and
O-GlcNacylation [22–26]. Although the post-translational regulations
of Drp1 are well elucidated, the regulation of Drp1 at the gene expres-
sion level is still poorly understood.
Gene expression is regulated at the level of transcription and trans-
lation. The post-transcriptional regulation of gene expression underlies
many aspects ofmammalian physiology and pathology [27,28]. The two
main groups of posttranscriptional regulators, RNA-binding proteins
(RBPs) and noncoding RNAs contribute to RNA splicing, transport,
mRNA stability, RNA storage as well as translational regulation [29,30].
These processes are associatedwith numerous cellular events, including
cell proliferation, differentiation, migration and cell death [31]. Howev-
er, the role of RBPs in the regulation of mitochondrial dynamics has not
been addressed to date. In the present study, we identiﬁed heteroge-
neous nuclear ribonucleoprotein A1 (hnRNP A1) as a novel regulator
of Drp1 expression. This protein directly interacts with Drp1 mRNA
and positively regulates Drp1 expression. Down-regulation of hnRNP
A1 was found to suppress both mitochondrial dysfunction and cell
death in 3-NP-treated cells, while, the over-expression of hnRNP A1 en-
hanced Drp1 expression and increased mitochondrial fragmentation.
Furthermore, hnRNP A1 potentiated 3-NP-induced mitochondrial
ﬁssion and cell death. Interestingly, we found that treatment with 3-
NP facilitates hnRNP A1 translocation to cytosol and signiﬁcantly
enhances the level of cytoplasmic hnRNP A1 bound Drp1 mRNA. Taken
together, these results suggest that hnRNP A1 regulates mitochondrial
dynamics by binding Drp1 mRNA.
2. Materials and methods
2.1. Cell culture and measurement of mitochondrial length
Neuroblastoma cells, SK-N-MC cells and SH-SY5Y cells were obtain-
ed from the American Type Culture Collection (ATCC, Manassas, VA).
Cells were cultured at 37 °C in a 5% CO2 incubator and maintained in
Dulbecco's modiﬁed Eagle's medium containing 10% fetal bovine
serum and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA).
In order to generate stably expressing cell lines (SK-N-MC/mito-YFP,
SK-N-MC/GFP and SK-N-MC/GFP-hnRNP A1), SK-N-MC cells were
transfected with pMito-YFP, pEGFP, and pEGFP-hnRNAP A1 using Lipo-
fectamine 2000 according to the manufacturer's protocol (Invitrogen,
Carlsbad, CA). The stable transfectants were selected based on their
growth in selection medium containing G418 (1 mg/ml) for 10 days.
After single cell dropping, the stably expressing clones were selected
under a ﬂuorescencemicroscope (IX71, Olympus, Japan) andwere con-
ﬁrmed by Western blotting. Mitochondrial lengths were measured
using the Cell Sense Standards software (Olympus, Hamburg,
Germany). The average mitochondrial length was determined after
selection of the arbitrary end of mitochondrial ﬁlament using the free-
hand line selection tool to measure length of individual mitochondria
obtained randomly selected 15–20 mitochondria per cell. And images
were analyzed and digitized using the Cell Sense Standards software.
2.2. Reagents
YFP-fused mito-tracker plasmid (pmito-YFP) was previously de-
scribed [32]. GFP-fused hnRNP A1 plasmid (pEGFP-hnRNP A1)was pur-
chased from Origene Technologies (Rockville, MD). 3-nitropropionic
acid (3-NP) was purchased from Sigma (St. Louis, MO). A mitoTracker®
probe and Hoechst 33,342 dye were purchased from Invitrogen
(Carlsbad, CA). The validated siRNAs targeting for hnRNP A1 (#1,5′-GCUCUUCAUUGGAGGGUUG-3′), (#2, 5′-CUACAAUGAUUUUGGG
AAUUU-3′) and a negative scrambled siRNA (5′-CCUACGCCACCAAU
UUCGU-3′) were purchased from Dharmacon (Thermo Scientiﬁc).
Previously validated Drp1 siRNA (5′-GAGGUUAUUGAACGACUCA-3′)
was synthesized from Bioneer (Daejeon, Korea) [32].
2.3. Biotin pull-down assay
In order to synthesize biotinylated transcripts, PCR fragments were
preparedusing forward primers containing the T7RNApolymerase pro-
moter sequence (T7, CCAAGCTTCTAATACGACTCACTATAGGGAGA), as
listed in Supplementary Table 1. Using the puriﬁed PCR products, bio-
tinylated transcripts were obtained by reverse transcription using the
MaxiScript T7 kit (Ambion, Waltham, MA) and biotin-CTP (Enzo Life
Sciences, Farmingdale, NY) [33]. Protein lysates (120 μg/sample) were
incubatedwith 1 μg of biotin labeled transcripts for 30min at room tem-
perature, and then, the protein-RNA complexes were isolated using
streptavidin-coupled Dynabeads (Invitrogen, Carlsbad, CA). Proteins
bound to biotinylated transcripts were assessed by Western blotting.
2.4. Ribonucleoprotein immunoprecipitation
Ribonucleoprotein immunoprecipitation assay was previously de-
scribed [34]. Brieﬂy, whole cell lysates were incubated with anti-
hnRNP A1 or control IgG-conjugated protein-A beads at 4 °C for 2 h.
After further incubation of immunoprecipitated complex with DNase I
and protease K, RNAs were isolated using acidic phenol. cDNAs were
synthesized using randomhexamers and reverse transcriptase (Toyobo,
Osaka, Japan) and relative Drp1 mRNA in immunoprecipitated com-
plexes was determined by real time quantitative PCR (RT-qPCR) with
2× SYBR green PCR master mix (Kapa Biosystems, Wilmington, MA)
and gene-speciﬁc primer sets (Supplementary Table 1) using StepOne
Plus™ instrument (Life Technologies, Waltham, MA).
2.5. Preparation of reporter plasmid and luciferase assay
Luciferase reporter plasmid containing 3′UTR sequence of Drp1
mRNA (2373–3535, 3U1 fragment) were generated by cloning of 3U1
fragment at the 3′UTR region of Renila luciferase gene of psiCHECH2
plasmid (Promega, Madison, WI). SH-SY5Y cells were transfected with
the reporter constructs (psiCHECK2 of psiDrp1 3U1) after transfection
of siRNAs or plasmids, respectively, and reporter activity was analyzed
using Dual Luciferase assay system (Promega). Fireﬂy luciferase activity
was used for normalization.
2.6. Western blotting and cell fractionation
All lysateswere preparedwith protein sample buffer (62.5mMTris–
HCl, pH 6.8, 25% glycerol, 2% SDS, 5% β-mercaptoethanol, 0.01%
Bromophenol blue) (BioRad, Hercules, CA). Then the samples separated
by SDS-PAGE were transferred to PVDF membrane (BioRad). After
blocking with 4% skim milk in TBST (25 mM Tris, 3 mM 140 mM NaCl,
0.05% Tween-20), the membranes were incubated overnight with spe-
ciﬁc primary antibodies at 4 °C. Anti-Drp1 antibody was from BD (San
Jose, CA); anti-hnRNP A1 was from Santa Cruz Biotechnologies (Santa
Cruz, CA); anti-cleaved caspase-3 was from Cell Signaling Technology
(Danvers, MA); anti-Actin antibody was from Millipore (Temecula,
CA). For protein detection, the membranes were incubated with HRP-
conjugated secondary antibodies (Pierce, Rockford, IL).
2.7. Measurement of mitochondrial membrane potential and ATP level
The loss ofmitochondrial membrane potential in the depolarizedmi-
tochondria was measured with a unique ﬂuorescent cationic dye, TMRE
(Tetramethylrhodamine ethyl ester, Invitrogen, Carlsbad, CA). Cells
treated with agents were incubated with TMRE, and the ﬂuorescence
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excitation and emissionwavelengths of (549 and 575). Cellular total ATP
level was detectedwith an ATP bioluminescence detection kit (Promega,
Madison, WI) according to the manufacturer's protocol.
2.8. Measurement of cytotoxicity
Cytotoxicity was quantitated by measuring lactate dehydrogenase
(LDH) release from damaged cells. LDH content was determined using
an LDH Cytotoxicity Detection Kit (Takara, San Diego, CA) according to
the manufacturer's protocol. Brieﬂy, cells transfected with either
siRNA or plasmid were exposed to 3-NP for 24 h. The total LDH activity
based on conversion the red formazanwas examined using spectropho-
tometry by measuring its absorbance at 490 nm compared with that of
untreated control cells.
2.9. Statistical analysis
Data were obtained from least three independent experiments, and
presented as means ± S.E.M. Statistical evaluation of the results was
performed with one-way ANOVA. Data were considered signiﬁcant at
a value of *p b 0.05.
3. Results
3.1. hnRNP A1 increases Drp1 expression through the interaction with 3′
UTR of Drp1 mRNA
RNAbinding proteins (RBPs) play critical roles in post-transcriptional
regulation as well as in RNA metabolism, thereby regulating geneFig. 1.hnRNP A1 regulatesDrp1 expression by binding its 3′UTR. (A) SH-SY5Y cell lysateswere s
RNAs in the precipitated complex, relative binding of Drp1mRNA to hnRNP A1was assessed by
gion (5′UTR), coding region (CR), 3′-untranslated region (3′UTR). The interaction between hnRN
analysis. After incubating biotinylated fragments with cell lysates, the bindingwas analyzed by
ative control. (C) SH-SY5Y cells were transfected with either hnRNP A1 siRNA (sihnRNP A1, lef
blottingwith indicated antibodies (upper panel) andDrp1mRNAwasmeasuredby RT-qPCR (lo
mRNA (psiDrp1 3U1) and control plasmid (psiCHECK2). (E) Relative reporter activity was asses
luciferase activity was normalized with ﬁreﬂy luciferase activity. Data are represented as the mexpression [30]. In order to examine the post-transcriptional regulation
of Drp1 expression, we synthesized and screened a small siRNA set
consisting of elucidated RBPs. Our ﬁndings revealed that hnRNP A1 reg-
ulates Drp1 expression in SH-SY5Y cells (Supplementary Fig. S1). In
order to verify the screening results,we further addressed the interaction
between hnRNP A1 and Drp1 mRNA in SH-SY5Y cells by ribonucleopro-
tein complex-immunoprecipitation (RNP-IP) assay. Consistent with the
screening results, Drp1 mRNA was signiﬁcantly enriched in the hnRNP
A1-containing IP complex compared with in the IgG control (Fig. 1A).
Since RBPs usually interact with 3′UTR of target mRNA and affect their
expressions, we prepared biotinylated fragments spanning 3′UTR of
Drp1 mRNA (3U1 and 3U2) and investigated interactions between
hnRNP A1 and biotin-labeled 3U1/3U2 fragments by Western blotting.
As shown in Fig. 1B, hnRNP A1 associated with 3U1 fragment of Drp1
mRNA but not with 3U2 fragment of negative control GAPDH, indicating
that hnRNP A1 interacts directly with Drp1 mRNA via its 3′UTR (U1 re-
gion). Next, we investigated whether hnRNP A1 affects Drp1 expression
by knock-down or over-expression of hnRNP A1. Although there was no
signiﬁcant change on the level of Drp1 mRNA by modulation of hnRNP
A1 expression, the protein level of Drp1 was notably decreased by
down-regulation of hnRNP A1 (Fig. 1C). Additionally, over-expression
of hnRNP A1 resulted in enhanced Drp1 expression in neuroblastoma
cells, suggesting that hnRNP A1 positively regulates Drp1 expression
(Fig. 1C). To further investigate whether hnRNP A1 increases Drp1 ex-
pression by binding its 3′UTR region, we established a luciferase reporter
plasmids harboring the 3U1 fragment of Drp1 mRNA and assessed re-
porter expression by luciferase activity assays after alteration of hnRNP
A1 levels (Fig. 1D). Consistently, down-regulation of hnRNP A1 de-
creased reporter expression harboring 3U1 fragment of Drp1 mRNA,
while ove- expression of hnRNP A1 enhanced luciferase activityubjected to RNP-IP complex using anti-hnRNPA1 antibody or control IgG. After isolation of
RT-qPCR. (B) Schematic description of the Drp1mRNA (NM_012062) 5′-untranslated re-
P A1 andbiotinylated transcripts ofDrp1mRNA3′UTRwas examined bybiotin-pull-down
Western blotting using hnRNP A1 antibody. GAPDH 3′UTR (GAPDH3U)was used as a neg-
t) or pHA-hnRNP A1 (hnRNP A1, right), and the protein levels were analyzed byWestern
wer panel). (D) Schematics of luciferase reporter plasmid containing 3U1 fragment of Drp1
sed by luciferase assay after transfection either siRNAs or plasmids in SH-SY5Y cells. Renilla
ean ± SEM (n = 3, and * p b 0.05 value).
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the 3′UTR of Drp1 mRNA and positively regulates Drp1 expression.
3.2. Down-regulation of hnRNP A1 increases mitochondrial elongation and
reduces Drp1 protein level
Drp1 plays important roles in various mitochondrial functions such
as mitochondrial morphology, motility, mitochondrial distribution and
biogenesis [2]. As our data showed that hnRNP A1 binds to Drp1
mRNA, we investigated the effect of hnRNP A1 on mitochondrial dy-
namics. SK-N-MC neuroblastoma cells stably expressing mito-tracker
fused YFP protein (SK-N-MC/mito-YFP) were transfected with siRNA
against hnRNP A1 (hnRNP A1, si#1, si#2), and mitochondrial morphol-
ogy was subsequently observed. In accordance with previous reports,
depletion of Drp1 by siRNAwas found to result inmitochondrial elonga-
tion. Interestingly, similar to what is seen with Drp1 depletion, knock-
down of hnRNP A1 was also found to induce mitochondrial elongation
(Fig. 2A). In addition, the length of mitochondrial ﬁlaments was signiﬁ-
cantly enhanced in cells with loss of hnRNP Al (Figs. 2B and C). The re-
duction of hnRNP A1 expression was conﬁrmed by Western blotting
(Fig. 2D). These results suggest that inhibition of hnRNP A1 induces mi-
tochondrial elongation by decreasing of Drp1 expression.
3.3. Down-regulation of hnRNP A1 inhibits 3-NP-mediated mitochondrial
dysfunction and cell death
Abnormal alterations of mitochondrial morphology, which affect
mitochondrial function, are related to neurodegenerative diseases
such as AD and HD [6,35]. In order to examine the effect of hnRNP A1
on mitochondrial dysfunction, SK-N-MC cells depleted hnRNP A1 orFig. 2. Down-regulation of hnRNP A1 induces mitochondrial elongation. SK-N-MC cells stably e
(Sc) or siRNA against hnRNP A1 (sihnRNP A1) for 3 days. (A) Representativeﬂuorescence pictur
control. (B and C) The mitochondrial length (B) and mitochondrial morphology (C) were mon
Drp1 by their siRNA was conﬁrmed by Western blot analysis with each antibody. Data are repDrp1 were further treated with 3-NP, and mitochondrial function and
cytotoxicity were assessed. As predicted, treatment with 3-NP induced
not only disrupted mitochondrial membrane potential but also de-
creased cellular ATP levels (Fig. 3A and B). However, the loss of mito-
chondrial membrane potential and ATP levels was signiﬁcantly
recovered by reduction of hnRNP A1 (Fig. 3A and B). Similarly, inhibi-
tion of Drp1 also reduced mitochondrial dysfunction in 3-NP treated
cells (Fig. 3A andB). Sincemitochondrial dysfunction is linked to the ini-
tiation of cell death, we further examined the effect of hnRNP A1 on 3-
NP-induced cytotoxicity. SK-N-MC cells transfected with siRNA for
hnRNP A1were further incubated with 3-NP and cell death and caspase
activation were addressed. Both cell death and caspase-3 activation
were increased after treatment with 3-NP. As with Drp1 knockdown,
loss of hnRNP A1 was also fond to inhibit cell death and caspase activa-
tion in 3-NP-treated cells (Fig. 3C and D). Collectively, these ﬁndings
indicate that mitochondrial elongation by hnRNP A1 depletion inhibits
3-NP-mediated mitochondrial dysfunction and cell death.
3.4. Over-expression of hnRNP A1 induces elevation of Drp1 protein level
Next, we examined the effect of over-expression of hnRNPA1 onmi-
tochondrial dynamics. SK-N-MC/hnRNP A1 cells stably expressing GFP-
fused-hnRNP A1 were stained with a mito-tracker dye. As shown in
Fig. 4A, hnRNP A1mainly localized to the nucleus, and the length of mi-
tochondria was shortened in hnRNP A1 over-expressing cells (Fig. 4A
and B). Then, we further investigated the Drp1 expression in hnRNP
A1 over-expressing cells. Consistent with our previous data, ectopic ex-
pression of hnRNP A1 increased Drp1 expression (Fig. 4C), suggesting
that over-expression of hnRNP A1 results in shortened mitochondrial
length by elevating Drp1 expression in neuroblastoma cells.xpressing mito-YFP (SK-N-MC/mito-YFP) were transfected with control scrambled siRNA
es showingmitochondrial morphology. The siRNA for Drp1 (siDrp1)was used as a positive
itored using a ﬂuorescence microscope. (D) The expression of hnRNP A1 (si#1, si#2) and
resented as the mean ± SEM (n N 3, and *p b 0.05 value).
Fig. 3.Down-regulation of hnRNP A1 inhibits 3-NP inducedmitochondrial dysfunction and cell death. SK-N-MC cells were transfectedwith either control scrambled siRNA (Sc) or speciﬁc
siRNA for hnRNP A1 (hnRNP A1 si#1, si#2) for 3 days. The cells were subjected to 3-NP (10 mM) treatment for 8 h. The siRNA for Drp1 (siDrp1) was used as a control. (A) Mitochondria
membrane potential was measured using a TMRE assay system. (B) The intracellular ATP level was determined using an ATP bioluminescence assay system. (C and D) SK-N-MC cells
transfected with either scrambled (Sc) or hnRNP A1 siRNA (si#1, si#2) for 3 days were treated with 3-NP (10 mM) for additional 24 h. (C) Cytotoxicity was measured by using a LDH
activity assay system. (D) The cell death was assessed by Western blotting with a cleaved caspase-3 antibody. Data are represented as the mean ± SEM (n N 3, and *p b 0.05 value).
1427S.J. Park et al. / Biochimica et Biophysica Acta 1849 (2015) 1423–14313.5. Over-expression of hnRNP A1 potentiates 3-NP-mediatedmitochondrial
dysfunction and cell death
Ourﬁndings showed that hnRNPA1-mediatedmitochondrial elonga-
tion suppressed mitochondrial fragmentation as well as mitochondrial
dysfunction in response to 3-NP. Therefore, we further addressed the
effect of hnRNP A1 over-expression on 3-NP-mediated mitochondrial
dysfunction. The mitochondrial membrane potential, total cellular ATPFig. 4.Over-expression of hnRNPA1enhances expression of Drp1. SK-N-MC cells stably expressi
were stained with a mito-tracker to imagemitochondria. Then the mitochondria morphologyw
mitochondrial morphology by over-expression of pEGFP (Vec) or pEGFP-hnRNP A1 (#1 and #2
(Olympus, Hamburg, Germany)with aﬂuorescencemicroscope. (C) The expressions of hnRNP A
mean ± SEM (n N 3, and *p b 0.05 value).levels, and mitochondrial morphology were examined in SK-N-MC
cells and SK-N-MC/hnRNP A1 cells treated with 3-NP. As expected,
over-expression of hnRNP A1 synergistically induced mitochondrial ﬁs-
sion in response to 3-NP treatment (Fig. 5A). Similarly, over-expression
of hnRNP A1 potentiated both loss ofmitochondrialmembrane potential
and the reduction of ATP levels in 3-NP treated cells (Fig. 5B and C). Next
we examined the effect of hnRNPA1 over-expression on cell death by in-
vestigating cytotoxicity in 3-NP-treated SK-N-MC cells and SK-N-MC/ng control GFP (SK-N-MC/GFP) orGFP-fused-hnRNPA1 (SK-N-MC/GFP-hnRNPA1, #1, #2)
asmonitored using a ﬂuorescence microscope. (A) Representative ﬂuorescence images of
). (B) Themitochondrial lengthwas determined by using a ‘Cell Sense Standards’ software
1 (#1, #2) andDrp1were conﬁrmed byWestern blot analysis. Data are represented as the
Fig. 5. Over-expression of hnRNP A1 potentiates 3-NP-mediated mitochondrial dysfunction and cell death. SK-N-MC/GFP and SK-N-MC/GFP-hnRNP A1 cells were treated with 3-NP
(10 mM) or not for 8 h. (A) Mitochondrial fragmentation was observed under a ﬂuorescence microscope. (B and C) The mitochondrial membrane potential (B) and intracellular ATP
level (C) were addressed using assay systems as described in the Materials and methods section. (D and E), SK-N-MC/GFP cells (Vec) and SK-N-MC/GFP-hnRNP A1 cells (hnRNP A1#1,
and #2) were treated with 3-NP (10 mM) for 24 h. And cytotoxicity and caspase activation were analyzed by LDH activity assay kit (D) and cleaved caspase-3 antibody (E). Data are
represented as the mean ± SEM (n N 3, and *p b 0.05 value).
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led to high cytotoxicity in response to 3-NP treatment in SK-N-MC cells
and SK-N-MC/hnRNP A1 cells than that of control cells. Furthermore,
we observed that the activation of capase-3was also increased as a result
of over-expression of hnRNP A1 and 3-NP treatment (Fig. 5E). Taken to-
gether, these results suggest that over-expression of hnRNP A1 aggra-
vates impaired mitochondrial function and cell death in response to
under 3-NP-treatment.
3.6. 3-NP promotes translocation of hnRNP A1 to the cytoplasm and
enhances Drp1 expression
hnRNPA1 is predominantly found in the nucleus, however, itmay be
shuttled from nucleus to cytoplasm under cellular stress conditions [36,
37]. As hnRNPA1was shown to regulatemitochondrial dynamics under
cytotoxic stress conditions, we investigated the effect of cellular locali-
zation of hnRNP A1 in response to such stress conditions. SK-N-MC/
hnRNP A1 cells were treated with 3-NP and the cellular location of
hnRNP A1 was observed. Our results conﬁrmed that hnRNP A1 was
mainly localized in the nucleus (Fig. 6A). Interestingly, treatment with
3-NP promoted the translocation of hnRNP A1 into the cytoplasm
(Fig. 6A). Cytoplasmic hnRNP A1 levels markedly increased in a time-
dependentmanner in 3-NP treated cells comparedwith those in control
cells (Fig. 6B). In addition, an increase of cytoplasmic hnRNP A1 was
conﬁrmed by factionation assay (Fig. 6C), suggesting that treatment
with 3-NP induces translocation of hnRNP A1 from nucleus to cyto-
plasm. As over-expression of hnRNP A1 increased the level of Drp1,
we additionally examined the effect of hnRNP A1 on Drp1 expression
in cells treated with 3-NP. Notably, treatment with 3-NP led to signiﬁ-
cant elevation of Drp1 expression in hnRNP A1 over-expressing cells(Fig. 6D). Because we observed that hnRNP A1 binds to Drp1 mRNA
and regulates its expression (Fig. 1), we further examined the associa-
tion between hnRNP and Drp1 mRNA after treatment with 3-NP. As
shown in Fig. 6E, treatment with 3-NP makedly resulted in an increas
of the interaction between hnRNP A1 and Drp1 mRNA compared with
that of mock-treated contol cells (Fig. 6E). Taken together, these results
indicate that 3-NP-mediated translocation of hnRNP A1 to the cyto-
plasm enhances Drp1 expression in neuroblastoma cells.
4. Discussion
Regulation of gene expression is important for multiple cellular pro-
cesses such as cellular proliferation, differentiation, development, and
cell death. Additionally, post-transcriptional regulation of gene expres-
sion underlies many aspects of cellular physiology as well as pathology.
The two main modulators of post-transcriptional regulation are RBPs
and noncoding RNAs [30,38]. RBPs participate in each step of RNA pro-
cessing, from transcription, splicing, and polyadenylation to RNAmodi-
ﬁcation, transport, translation, and turnover [30]. MicroRNAs (miRNA)
are small non-coding RNAs that function in gene silencing by modulat-
ingmRNA translation as well as mRNA degradation [39]. Recent studies
have reported post-transcriptional regulation of mitochondrial dynam-
ics. Wang and Li et al. showed that miR-499 and miR-30 affect mito-
chondrial ﬁssion machinery by targeting Drp1 [40,41]. In addition, it
was reported that HuR, a member of the ELAV family of RNA binding
proteins directly binds to the 5′UTR of Bcl-xL mRNA, and that inhibition
of HuR modulates mitochondrial morphology in U2OS cells [42]. How-
ever, the role of RBPs in mitochondrial dynamics is largely unknown.
In the present study, we ﬁrstly showed that hnRNP A1 regulates Drp1
expression by directly binding to Drp1 mRNA.
Fig. 6. 3-NP induces cytosolic translocalization of hnRNP A1 and enhances Drp1 expression. SK-N-MC/GFP-hnRNP A1 cells (#1 and #2)were incubated in the presence or absence of 3-NP
(10mM) for 16 h. (A) The cells were stained with a Hoechst dye for nuclear staining. Cytoplasmic translocation of hnRNP A1was imaged by a ﬂuorescence microscopy. (B) Cells showing
cytoplasmic hnRNP A1 in the presence of 3-NP were counted with a ﬂuorescence microscope. (C) Cytoplasmic RNP A1 was determined by cell fractionation and Western blotting with
indicated antibodies. Both lamin B andGAPDHwere used for controls. (D and E) SK-N-MC/hnRNP A1 cells (#1 and #2) exposed to 3-NP for 24 hwere harvested and analyzed byWestern
blotting using Drp1 antibody (D). The cell lysates were subjected to RNP complex immunoprecipitation followed by RT-qPCR analysis to detect enriched Drp1mRNA in hnRNP A1 immu-
noprecipitates (hnRNP A1). Data are represented as the mean ± SEM (n N 3, and *p b 0.05 value).
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small-scale siRNA library set composed of 10 well-elucidated RBPs.
We screened the siRNA library set and identiﬁed hnRNP A1 as a novel
regulator of Drp1 expression in neuroblastoma cells (Fig. 1 and Supple-
mentary Fig. S1). hnRNP A1, which belongs to the hnRNP subfamily,
plays a role in pre-mRNA splicing, and predominantly localizes to the
nucleus [43,44]. hnRNAP A1 is also known to function as a post-
transcriptional regulator, inﬂuencing mRNA turnover and translation
in cytoplasm [45]. Various targets, such as the mRNAs for cyclin D1,
c-Myc and interleukin-2, are post-transcriptionally regulated by
hnRNP A1 [46,47]. In the present study, we showed that hnRNP A1
affects Drp1 expression and regulates mitochondrial dynamics
(Figs. 1 and 2). RBPs possess several RNA binding domains such as
the RNA-recognition motif (RRM), serine/arginine-rich splicing fac-
tors (SR), K-homology domain (KH), and RGG box domain [48].
Structural analysis indicates that hnRNP A1 contains two RRM domains
at the N-terminus, an RGG domain in themiddle part, and aM9 domain
that includes the nucleus localization sequence at the C-terminus. We
showed that the 3′UTR (U1 region) of Drp1 mRNA is involved in the in-
teraction with hnRNP A1. However, further elucidation of the speciﬁc
domains of hnRNP A1 that mediate this interaction should help in un-
derstanding the biochemical mechanism underlying the regulation of
Drp1 by hnRNP A1.
The disruption of mitochondrial dynamics is associated with the
pathogenesis of several neurodegenerative diseases [6,35]. HD is caused
by mutations of the Huntingtin (HTT). The mutant HTT directly binds to
Drp1 and increases its GTPase activity, leading to a massive mitochon-
drial fragmentation and neuronal damage [49]. Interestingly, it wasrecently reported that mitochondrial ﬁssion mediators such as Drp1
and Fis1 were increased in the post-mortem brains of HD patients,
whereas mitochondrial fusion inducers such as OPA1 and Mfn1/2
were decreased [10,50]. The 3-NP toxin when administered to rodents
mimics aspects of the pattern of cell loss seen in HD [9]. 3-NP enhances
reactive oxygen species (ROS) and reactive nitrogen species (RNS)
which induce mitochondrial fragmentation and cell death in neuronal
cells [15,51]. Inhibition of Drp1 suppresses RNS-mediated mitochondri-
al ﬁssion and neuronal injury [15,24,51,52]. In this study, we showed
that hnRNPA1 regulatesmitochondrial dysfunction and cell death in re-
sponse to 3-NP (Figs. 3 and 5). Recently, it was reported that the re-
duced hnRNP A1 level in the brain tissues of AD patients is associated
with impaired learning and memory ability [53]. However, it is still un-
clearwhether the correlation between hnRNPA1 andmitochondrial dy-
namics is involved in HD or not. It could be possible that altered hnRNP
A1 expression modulates mitochondrial morphology by controlling
Drp1 expression in HD. Therefore, further investigation of the expres-
sion of hnRNP A1 in HD should help elucidate the role of hnRNP A1 in
HD pathogenesis.
It was reported that hnRNP A1 is redistributed to the cytosol under
certain stress conditions [37,45]. Osmotic stress and ultra-violet-irradi-
ation resulted in cytoplasmic accumulation of phosphorylated hnRNP
A1 [37,45,54]. In addition, MNK1 acting downstream of p38 kinase, reg-
ulates the phosphorylation and subcellular distribution of hnRNPduring
the senescence of ﬁbroblasts [55]. Intriguingly, we also found that treat-
ment with the neurotoxin, 3-NP, efﬁciently induced translocation of
hnRNP A1 from nucleus to cytoplasm, and enhanced its binding afﬁnity
to Drp1 mRNA (Fig. 6). Recently, Jang et al. showed that the
1430 S.J. Park et al. / Biochimica et Biophysica Acta 1849 (2015) 1423–1431phosphorylation of MAPKs such as JNK, ERK1/2, and p38, was increased
in 3-NP-injectedmice, and inhibition of p38 and ERK1/2 prevented neu-
rological impairment induced by 3-NP [56]. The mechanisms underly-
ing 3-NP-mediated translocation of hnRNP A1 need to be further
elucidated in HD models, however, our results suggest that hnRNP A1
induces mitochondrial fragmentation and dysfunction by increasing
Drp1 expression in 3-NP-treated cells. Since excessive mitochondrial
ﬁssion and dysfunction are known to be hallmarks of neurodegenera-
tive disease, it is necessary to elucidate the precise mechanism by
which hnRNP A1 regulates Drp1 expression in various neurodegenera-
tive diseases.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbagrm.2015.10.017.
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